IPNY, Inc.

New York, United States

Contact Information

420 Lexington Avenue, Suite 1756
New York NY 10170
telefon: +1 212.488.4769
web sitesi:

Tom Steadman

Tom Steadman

Managing Director

telefon: 212-488-4774


Basic Info

temel yetkinlikler: Digital, Marketing/Creative Services, Direct/Tele/Database Marketing/CRM, Healthcare, Financial

Bulunan yer: 2012

Çalışan: 30

Ödüller: 7

Yaratıcı Çalışma: 88

Müşteriler: 16

temel yetkinlikler: Digital, Marketing/Creative Services, Direct/Tele/Database Marketing/CRM, Healthcare, Financial

Bulunan yer: 2012

Çalışan: 30

Ödüller: 7

Yaratıcı Çalışma: 88

Müşteriler: 16

IPNY, Inc.

420 Lexington Avenue, Suite 1756
New York NY 10170
telefon: +1 212.488.4769
web sitesi:
Tom Steadman

Tom Steadman

Managing Director

telefon: 212-488-4774

Dana-Farber Selected New York’s IPNY - New Healthcare Client for the Agency

IPNY, Inc.
Full Service
New York, United States
See Profile
 

IPNY, the brand positioning and messaging company, is proud to announce that it has been selected by Dana-Farber Cancer Institute to develop its new multi-channel brand launch campaign.  A US News and World Report top-rated cancer treatment center, Dana-Farber (based in Boston, MA) has a 70+ year history of discovery and innovation in cancer research and care.  

 

This is IPNY’s first engagement with Dana-Farber, although the agency has a long history of working with healthcare providers and specifically hospital networks as clients.

 

“The campaign creatively and effectively speaks to the worldwide impact of Dana-Farber’s research and expertise,” says Donna Lee Ubertalli, V.P. of Marketing for Dana-Farber.

 

Andy Semons, Founding and Strategic Planning Partner at IPNY continued, “Partnering with Dana-Farber to help them broaden their brand presence in the area of cancer research, particularly outside of the New England area, is gratifying, especially since they have such stellar credentials.  Notably, earlier this month one of their researchers was the recipient of the Nobel Prize in medicine.”

 

The campaign, which includes television, print and digital elements, is designed to elevate the profile of Dana-Farber as a leader in the cancer treatment landscape and show the global impact of discoveries such as PD-L1, which revolutionized modern immunotherapy.  The campaign, entitled “Change the World”, is launching the week of October 28.  Here is one of the television commercials.  The first media flight will air through December, with subsequent media planned for February 2020 and beyond. 

 

About Dana-Farber Cancer Institute

Dana-Farber Cancer Institute is one of the world’s leading centers of cancer research and treatment. It is ranked in the top 5 of U.S. News and World Report’s Best Hospitals for both adult and pediatric cancer care. Dana-Farber’s mission is to reduce the burden of cancer through scientific inquiry, clinical care, education, community engagement, and advocacy.  We provide the latest in cancer for adults throughDana-Farber/Brigham and Women's Cancer Care and for children through Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Dana-Farber is dedicated to a unique and equal balance between cancer research and care, translating the results of discovery into new treatments for patients locally and around the world.